Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

[1]  J. Knowles,et al.  Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. , 2016, American heart journal.

[2]  J. Knowles,et al.  Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials). , 2016, The American journal of cardiology.

[3]  J. Knowles,et al.  Nat1 Deficiency Is Associated with Mitochondrial Dysfunction and Exercise Intolerance in Mice. , 2016, Cell reports.

[4]  J. Knowles,et al.  Hypertriglyceridemia: A simple approach to identify insulin resistance and enhanced cardio-metabolic risk in patients with prediabetes. , 2016, Diabetes research and clinical practice.

[5]  E. Ashley,et al.  Interdisciplinary psychosocial care for families with inherited cardiovascular diseases. , 2016, Trends in cardiovascular medicine.

[6]  J. Knowles,et al.  Novel Therapies for Familial Hypercholesterolemia , 2016, Current Treatment Options in Cardiovascular Medicine.

[7]  Emily C. O'Brien,et al.  US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry. , 2016, Journal of clinical lipidology.

[8]  J. Knowles,et al.  Standards of Evidence and Mechanistic Inference in Autosomal Recessive Hypercholesterolemia. , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[9]  J. Knowles.  Statins in Familial Hypercholesterolemia: Translating Evidence to Action. , 2016, Journal of the American College of Cardiology.

[10]  J. Knowles,et al.  Enough Evidence, Time to Act! , 2016, Circulation.

[11]  E. Ashley,et al.  Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy , 2016, Echocardiography.

[12]  Russ B Altman,et al.  Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity , 2016, Nature Medicine.

[13]  J. Knowles,et al.  Usual Blood Pressure and New-Onset Diabetes Risk: Evidence From 4.1 Million Adults and a Meta-Analysis. , 2016, Journal of the American College of Cardiology.

[14]  Emily C. O'Brien,et al.  Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry , 2016, Circulation. Cardiovascular genetics.

[15]  J. Knowles,et al.  Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists , 2016, Current Atherosclerosis Reports.

[16]  C. Morse,et al.  The impact of obesity on skeletal muscle strength and structure through adolescence to old age , 2015, Biogerontology.

[17]  G. Shaw,et al.  Maternal Midpregnancy Glucose Levels and Risk of Congenital Heart Disease in Offspring. , 2015, JAMA pediatrics.

[18]  Matthew K Ito,et al.  The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. , 2015, Circulation.

[19]  Emily C. O'Brien,et al.  Abstract 12169: LDL-C Levels and Treatment Patterns Among Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry , 2015 .

[20]  J. Knowles,et al.  Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts. , 2015, The American journal of cardiology.

[21]  T. Assimes,et al.  Corrigendum: Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example , 2015, Front. Genet..

[22]  G. Matheson,et al.  Systematic Comparison of Digital Electrocardiograms From Healthy Athletes and Patients With Hypertrophic Cardiomyopathy. , 2015, Journal of the American College of Cardiology.

[23]  E. Ashley,et al.  Prevalence and prognostic role of right ventricular involvement in stress-induced cardiomyopathy. , 2015, Journal of cardiac failure.

[24]  Emily C. O'Brien,et al.  Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry*† , 2015 .

[25]  E. Ashley,et al.  Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. , 2015, JACC. Heart failure.

[26]  T. Assimes,et al.  Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. , 2015, The Journal of clinical investigation.

[27]  J. Knowles,et al.  NAT1 KNOCKDOWN RESULTS IN AN INSULIN RESISTANCE PHENOTYPE IN VITRO AND IN VIVO , 2015 .

[28]  Emily C. O'Brien,et al.  INITIAL RESULTS FROM THE CASCADE-FH REGISTRY: CASCADE SCREENING FOR AWARENESS AND DETECTION OF FAMILIAL HYPERCHOLESTEROLEMIA , 2015 .

[29]  J. Knowles,et al.  PCSK9 Inhibition: Current Concepts and Lessons from Human Genetics , 2015, Current Atherosclerosis Reports.

[30]  Emily C. O'Brien,et al.  Reducing the burden of disease and death from familial hypercholesterolemia: a call to action. , 2014, American heart journal.

[31]  P. Munroe,et al.  Genetic Evidence for a Normal-Weight “Metabolically Obese” Phenotype Linking Insulin Resistance, Hypertension, Coronary Artery Disease, and Type 2 Diabetes , 2014, Diabetes.

[32]  Sanjiv J. Shah,et al.  Cardiovascular Genetics and Genomics in Clinical Practice , 2014 .

[33]  John P. A. Ioannidis,et al.  Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example , 2014, Front. Genet..

[34]  E. Ashley,et al.  Unexplained Double‐Chambered Left Ventricle Associated with Contracting Right Ventricular Aneurysm and Right Atrial Enlargement , 2014, Echocardiography.

[35]  M. Perez,et al.  Variation in Use of Left Ventriculography in the Veterans Affairs Health Care System , 2013, Circulation. Cardiovascular quality and outcomes.

[36]  D. Absher,et al.  Trans-ethnic fine mapping identifies a novel independent locus at the 3′ end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese population , 2013, Diabetologia.

[37]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[38]  J. Knowles,et al.  Role of international registries in enhancing the care of familial hypercholesterolaemia. , 2013, International journal of evidence-based healthcare.

[39]  Jussi Paananen,et al.  Genetic Variants Associated With Glycine Metabolism and Their Role in Insulin Sensitivity and Type 2 Diabetes , 2013, Diabetes.

[40]  Donald M Bers,et al.  Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.

[41]  T. Assimes,et al.  Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp. , 2013, Metabolism: clinical and experimental.

[42]  E. Ashley,et al.  Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy. , 2013, The American journal of cardiology.

[43]  T. Assimes,et al.  Abstract 10916: Mendelian Randomization Studies Do Not Support a Causal Effect of Plasma Lipids on Insulin Sensitivity , 2012 .

[44]  J. Knowles,et al.  Exploring predisposition and treatment response--the promise of genomics. , 2012, Progress in cardiovascular diseases.

[45]  D. Absher,et al.  Randomized Trial of Personal Genomics for Preventive Cardiology: Design and Challenges , 2012, Circulation. Cardiovascular genetics.

[46]  D. Absher,et al.  Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution , 2011, Nature Genetics.

[47]  Omar E. Cornejo,et al.  Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence , 2011, PLoS genetics.

[48]  D. Rader,et al.  Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[49]  Jennifer G. Robinson,et al.  Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[50]  T. Brennan,et al.  OVERUSE OF LEFT VENTRICULOGRAPHY , 2011 .

[51]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[52]  Yan V. Sun,et al.  A Bivariate Genome-Wide Approach to Metabolic Syndrome , 2011, Diabetes.

[53]  Muin J Khoury,et al.  Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence , 2010, Genetics in Medicine.

[54]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[55]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[56]  Alexander A. Morgan,et al.  Clinical assessment incorporating a personal genome , 2010, The Lancet.

[57]  Sophie Page.  Magic , 2010, The Classical Review.

[58]  D. Absher,et al.  Characterizing the admixed African ancestry of African Americans , 2009, Genome Biology.

[59]  J. Witteman,et al.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.

[60]  S. Humphries,et al.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study , 2008, European heart journal.

[61]  Jun Li,et al.  Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. , 2008, Human molecular genetics.

[62]  T. Assimes,et al.  A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. , 2008, Atherosclerosis.

[63]  T. Assimes,et al.  Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD , 2008, BMC Medical Genetics.

[64]  T. Assimes,et al.  Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease , 2008, Human Genetics.

[65]  E. Ashley,et al.  Pharmacogenetics of Heart Failure: Evidence, Opportunities, and Challenges for Cardiovascular Pharmacogenomics , 2008, Journal of cardiovascular translational research.

[66]  R. Myers,et al.  Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. , 2007, American heart journal.

[67]  T. Assimes,et al.  Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[68]  J. Knowles,et al.  A case of complete heart block reverting to normal sinus rhythm after treatment for cardiac invasive Burkitt’s lymphoma , 2007, Annals of Hematology.

[69]  J. Knowles,et al.  Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Kastelein,et al.  Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. , 2004, Seminars in vascular medicine.

[71]  T. Leren,et al.  Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program. , 2004, Seminars in vascular medicine.

[72]  F. Civeira,et al.  Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. , 2004, Seminars in vascular medicine.

[73]  J. Knowles,et al.  Increased Atherosclerosis and Smooth Muscle Cell Hypertrophy in Natriuretic Peptide Receptor A−/−Apolipoprotein E−/− Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[74]  J. Kastelein,et al.  Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia. , 2003, Archives of internal medicine.

[75]  J. Knowles,et al.  Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. , 2002, American journal of physiology. Heart and circulatory physiology.

[76]  J. Knowles,et al.  Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. , 2002, The Journal of clinical investigation.

[77]  J. Knowles,et al.  Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide. , 2001, The Biochemical journal.

[78]  J. Knowles,et al.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. , 2001, The Journal of clinical investigation.

[79]  E. Sijbrands,et al.  Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands , 2001, The Lancet.

[80]  D. Bhatnagar,et al.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia , 2000, BMJ : British Medical Journal.

[81]  J. Knowles,et al.  Genetic Modifiers of Atherosclerosis in Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[82]  S. Humphries,et al.  Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study , 2000, BMJ : British Medical Journal.

[83]  N. Calonge,et al.  Validation of self-reported chronic conditions and health services in a managed care population. , 2000, American journal of preventive medicine.

[84]  J. Knowles,et al.  Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. , 2000, The Journal of clinical investigation.

[85]  R. Escorpizo,et al.  Challenges and Opportunities , 1999, Deep Eutectic Solvents for Pretreatment of Lignocellulosic Biomass.

[86]  J. Knowles,et al.  Low salt intake down-regulates the guanylin signaling pathway in rat distal colon. , 1996, Gastroenterology.

[87]  M. C. Leske,et al.  Comparing self-reported and physician-reported medical history. , 1994, American journal of epidemiology.

[88]  M. Leppert,et al.  Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. , 1993, The American journal of cardiology.

[89]  S. Rose.  HUMAN PERFECTIBILITY , 1984, The Lancet.

[90]  J. Slack.  RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES , 1969 .

[91]  May E. Montasser,et al.  Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders , 2014 .

[92]  Tanya M. Teslovich,et al.  Association analyses of 249 , 796 individuals reveal 18 new loci associated with body mass index , 2012 .

[93]  Michael Higgins,et al.  An Electronic Health Record - Public Health (EHR-PH) System Prototype for Interoperability in 21st Century Healthcare Systems , 2005, AMIA.

[94]  S. Humphries,et al.  HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEWS Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review , 2004 .

[95]  J. Knowles.  Genes That Modify Susceptibility to Atherosclerosis: Targets for Drug Action , 2004 .

[96]  J. Knowles,et al.  Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects , 2002, Human Genetics.

[97]  A. Zuccalà.  Dyslipidemia and hypertension: twin killers in renal vascular disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[98]  S. Humphries,et al.  MED-PED: An Integrated Genetic Strategy for Preventing Early Deaths , 1996 .

[99]  Y. Christen,et al.  Genetic Approaches to Noncommunicable Diseases , 1996, Springer Berlin Heidelberg.

[100]  Charles R.scriver.  The Metabolic basis of inherited disease , 1989 .

[101]  E. Magavern,et al.  Peer Review History , 2022 .